Cargando…

Pre-clinical testing of malignant fibroblast activation protein-specific re-directed T cells for treatment of pleural mesothelioma

Detalles Bibliográficos
Autores principales: Schuberth, Petra C, Hagedorn, Christian, Jensen, Shawn M, Gulati, Pratiksha, Belaunzaran, Osiris Marroquin, Soltermann, Alex, Jüngel, Astrid, Renner, Christoph, Petrausch, Ulf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991289/
http://dx.doi.org/10.1186/2051-1426-1-S1-P35
_version_ 1782312409726189568
author Schuberth, Petra C
Hagedorn, Christian
Jensen, Shawn M
Gulati, Pratiksha
Belaunzaran, Osiris Marroquin
Soltermann, Alex
Jüngel, Astrid
Renner, Christoph
Petrausch, Ulf
author_facet Schuberth, Petra C
Hagedorn, Christian
Jensen, Shawn M
Gulati, Pratiksha
Belaunzaran, Osiris Marroquin
Soltermann, Alex
Jüngel, Astrid
Renner, Christoph
Petrausch, Ulf
author_sort Schuberth, Petra C
collection PubMed
description
format Online
Article
Text
id pubmed-3991289
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39912892014-05-05 Pre-clinical testing of malignant fibroblast activation protein-specific re-directed T cells for treatment of pleural mesothelioma Schuberth, Petra C Hagedorn, Christian Jensen, Shawn M Gulati, Pratiksha Belaunzaran, Osiris Marroquin Soltermann, Alex Jüngel, Astrid Renner, Christoph Petrausch, Ulf J Immunother Cancer Poster Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3991289/ http://dx.doi.org/10.1186/2051-1426-1-S1-P35 Text en Copyright © 2013 Schuberth et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Schuberth, Petra C
Hagedorn, Christian
Jensen, Shawn M
Gulati, Pratiksha
Belaunzaran, Osiris Marroquin
Soltermann, Alex
Jüngel, Astrid
Renner, Christoph
Petrausch, Ulf
Pre-clinical testing of malignant fibroblast activation protein-specific re-directed T cells for treatment of pleural mesothelioma
title Pre-clinical testing of malignant fibroblast activation protein-specific re-directed T cells for treatment of pleural mesothelioma
title_full Pre-clinical testing of malignant fibroblast activation protein-specific re-directed T cells for treatment of pleural mesothelioma
title_fullStr Pre-clinical testing of malignant fibroblast activation protein-specific re-directed T cells for treatment of pleural mesothelioma
title_full_unstemmed Pre-clinical testing of malignant fibroblast activation protein-specific re-directed T cells for treatment of pleural mesothelioma
title_short Pre-clinical testing of malignant fibroblast activation protein-specific re-directed T cells for treatment of pleural mesothelioma
title_sort pre-clinical testing of malignant fibroblast activation protein-specific re-directed t cells for treatment of pleural mesothelioma
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991289/
http://dx.doi.org/10.1186/2051-1426-1-S1-P35
work_keys_str_mv AT schuberthpetrac preclinicaltestingofmalignantfibroblastactivationproteinspecificredirectedtcellsfortreatmentofpleuralmesothelioma
AT hagedornchristian preclinicaltestingofmalignantfibroblastactivationproteinspecificredirectedtcellsfortreatmentofpleuralmesothelioma
AT jensenshawnm preclinicaltestingofmalignantfibroblastactivationproteinspecificredirectedtcellsfortreatmentofpleuralmesothelioma
AT gulatipratiksha preclinicaltestingofmalignantfibroblastactivationproteinspecificredirectedtcellsfortreatmentofpleuralmesothelioma
AT belaunzaranosirismarroquin preclinicaltestingofmalignantfibroblastactivationproteinspecificredirectedtcellsfortreatmentofpleuralmesothelioma
AT soltermannalex preclinicaltestingofmalignantfibroblastactivationproteinspecificredirectedtcellsfortreatmentofpleuralmesothelioma
AT jungelastrid preclinicaltestingofmalignantfibroblastactivationproteinspecificredirectedtcellsfortreatmentofpleuralmesothelioma
AT rennerchristoph preclinicaltestingofmalignantfibroblastactivationproteinspecificredirectedtcellsfortreatmentofpleuralmesothelioma
AT petrauschulf preclinicaltestingofmalignantfibroblastactivationproteinspecificredirectedtcellsfortreatmentofpleuralmesothelioma